|
|
|||||||
|
APPENDIX A The Guideline for the Management of Opioid Therapy for Chronic Pain is the product of many months of diligent effort and consensus building among knowledgeable individuals from the Veterans Administration (VA), Department of Defense (DoD), academia, and guideline facilitators from the private sector. An experienced moderator facilitated the multidisciplinary Working Group that included primary care physicians, pain specialists, rehabilitation specialists, anesthesiologists, psychiatrists, psychologists, pharmacists, nurses, and social workers, as well as consultants in the field of guideline and algorithm development. Development Process "Only well-focused questions and search terms will lead to a successful search for evidence" (AHCPR, 1996). The process of developing this guideline was evidence-based whenever possible. Evidence-based practice integrates clinical expertise with the best available clinical evidence derived from systematic research. Where evidence is ambiguous or conflicting, or where scientific data are lacking, the clinical experience of the multidisciplinary Working Group was used to guide the development of consensus-based recommendations. The developers incorporated the evidence and recommendations into a format that would maximally facilitate clinical decision-making (Woolf, 1992). The review of the literature, evaluation of evidence, and development of the guideline proceeded in sequential steps. The following six documents were identified by the Working Group as appropriate seed guidelines. They served as the starting point for the development of questions and key terms.
Five researchable questions and associated key terms were developed by the Working Group after orientation to the seed guidelines and to goals that had been identified by the Working Group. The questions specified:
A systematic search of the literature was conducted for each key question, starting with studies at the top of the hierarchy of study types—evidence-based reviews and clinical trials. In addition to PubMed, the following databases were searched: Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effectiveness (DARE), and Cochrane Central Register of Controlled Trials (CCTR). For PubMed, limits were set for language (English), data of publication (1998 through July 2002) and type of research (randomized controlled trial [RCT] and meta-analysis). For the CCTR, limits were set for date of publication (1998 through 2002). The results of the search were organized and reported using reference manager software. At this point, additional exclusion criteria were applied. Typical exclusions were studies with physiological endpoints, or studies of populations that were not comparable to the population of interest. Once definitive clinical studies that addressed the question were identified, the search stopped. It was extended to studies/reports of lower quality only if there were no high quality studies. Evidence Appraisal Reports for each of the five questions were prepared by the Center for Evidence-Based Practice at the State University of New York, Upstate Medical University, Department of Family Medicine and by ACS staff (These reports are available by request.) Each report covered:
The Working Group suggested some additional references. Copies of specific articles were provided to participants on an as-needed basis. The clinical experts and the research team evaluated the evidence for each question according to criteria proposed by the U.S. Preventive Services Task Force (USPSTF) (2001). See "Rating the Evidence," below. The Working Group participated in two face-to-face sessions to reach a consensus about the guideline recommendations and to prepare a draft document. The draft was revised by the experts through numerous conference calls and individual contributions to the document. The guideline presents evidence-based recommendations that have been thoroughly evaluated by practicing clinicians.. Nonetheless, this document is a work in progress. It will be updated every two years, or when significant new evidence is published. Evidence-based practice involves integrating clinical expertise with the best available clinical evidence derived from systematic research. The Working Group reviewed the evidence and graded it using the rating scheme developed by the USPSTF (2001). The experts themselves, after an orientation and tutorial on the evidence grading process, formulated Quality of Evidence ratings (see Table 1), a rating of Overall Quality (see Table 2), a rating of the Net Effect of the Intervention (see Table 3), and an overall Recommendation (see Table 4).
Abstract of the USPSTF:
Algorithms The overall view of the Opioid Therapy for Chronic Pain guideline is presented in an algorithmic format. There are indications that this format improves data collection and clinical decision-making and helps to change patterns of resource use. It allows the clinician to follow a linear approach to critical information needed at the major decision points in the clinical process, and includes:
A clinical algorithm diagrams a guideline into a step-by-step decision tree. Standardized symbols are used to display each step in the algorithm (SMDMC, 1992). Arrows connect the numbered boxes indicating the order in which the steps should be followed.
A letter within a box of an algorithm refers the reader to the corresponding annotation. The annotations elaborate on the recommendations and statements that are found within each box of the algorithm. Included in the annotations are brief discussions that provide the underlying rationale and specific evidence tables. A complete bibliography, which includes all the sources used-directly or indirectly-in the development of the text, is provided at the end of the document. REFERENCES Agency for Health Care Policy and Research (AHCPR).
Manual for Conducting Systematic Review. Draft. August 1996. Prepared
by Steven H. Woolf.
American Academy of Pain Medicine and American Pain
Society. The Use of Opioids for the Treatment of Chronic Pain. (1996)
Canadian Pain Society. Use of opioid analgesics for
the treatment of chronic noncancer pain – A consensus statement
and guidelines from the Canadian Pain Society. (1998)
Cochrane Reviews, Cochrane Controlled Trials Register
at http://www.update-software.com/cochrane
.
College of Physicians and Surgeons of Ontario. Evidence-Based
Recommendations for Medical Management of Chronic Non-Malignant Pain.
(2000)
Harden, R. Norman MD. Chronic Opioid Therapy: Another
Reappraisal. Available at http://www.ampainsoc.org/pub/bulletin/jan02/poli1.htm.
Harris RP, Helfand M, Woolf SH. Current methods of
the U.S. Preventive Services Task Force. A review of the process. Am J
Prev Med 2001.
Portenoy, R.K. Opioid therapy for chronic nonmalignant
pain: a review of the critical issues. J Pain Symptom Manage. 1996 Apr;
11(4):203-17.
Society for Medical Decision-Making Committee (SMDMC).
Proposal for clinical algorithm standards,MDMC on Standardization of Clinical
Algorithms. In: Medical Decision Making 1992; 12(2):149-54.
United States Preventive Service Task Force (USPSTF).
Guide to Clinical Preventive Services. 2nd edition. Baltimore: Williams
and Wilkins, 1996.
VA 1996 External Peer Review Program. Contract No.
V101(93) P-1369.
Washington State Department of Labor and Industries.
Guideline for Outpatient Prescription of Oral Opioids for Injured Workers
with Chronic, Noncancer Pain. (2000)
Woolf SH. Practice guidelines, a new reality in medicine
II. Methods of developing guidelines. Archives of Intern Med 1992; 152:947-948.
|